| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10008756 | Annals of Allergy, Asthma & Immunology | 2005 | 5 Pages |
Abstract
The low rate of adverse reactions to etoricoxib, tested by oral challenge, suggests that patients with previous cutaneous hypersensitivity reactions to NSAIDs (primarily urticaria and angioedema) may tolerate this drug.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Eustachio MD, Maria Cristina MD, Antonio MD, Angelo MD, Alfredo MD,